NACCHIO, MARIANTONIA
 Distribuzione geografica
Continente #
AS - Asia 2.014
NA - Nord America 1.948
EU - Europa 1.709
SA - Sud America 241
Continente sconosciuto - Info sul continente non disponibili 100
AF - Africa 44
OC - Oceania 6
Totale 6.062
Nazione #
US - Stati Uniti d'America 1.863
SG - Singapore 813
RU - Federazione Russa 701
IT - Italia 485
VN - Vietnam 420
CN - Cina 320
BR - Brasile 193
HK - Hong Kong 180
DE - Germania 122
NL - Olanda 78
BD - Bangladesh 69
FR - Francia 67
GB - Regno Unito 61
IN - India 57
CA - Canada 44
FI - Finlandia 42
JP - Giappone 30
KR - Corea 28
AR - Argentina 26
MX - Messico 25
ES - Italia 23
GR - Grecia 18
PL - Polonia 18
UA - Ucraina 18
CI - Costa d'Avorio 14
IQ - Iraq 13
PH - Filippine 13
AT - Austria 12
EC - Ecuador 12
LT - Lituania 12
ZA - Sudafrica 11
IE - Irlanda 10
SE - Svezia 10
TH - Thailandia 10
PK - Pakistan 8
UZ - Uzbekistan 8
ID - Indonesia 6
TR - Turchia 6
TW - Taiwan 6
AU - Australia 5
CZ - Repubblica Ceca 5
EG - Egitto 5
RO - Romania 5
BE - Belgio 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BS - Bahamas 3
CO - Colombia 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
MY - Malesia 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
DZ - Algeria 2
EE - Estonia 2
KZ - Kazakistan 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
BB - Barbados 1
BF - Burkina Faso 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 5.965
Città #
San Jose 411
Singapore 392
Ashburn 186
Hong Kong 173
Moscow 150
Naples 126
Chandler 123
Ho Chi Minh City 117
Beijing 105
Hanoi 103
Hefei 69
Santa Clara 64
Los Angeles 63
Council Bluffs 59
Munich 58
The Dalles 50
Amsterdam 41
Lauterbourg 39
New York 39
Millbury 29
Helsinki 26
Lawrence 26
São Paulo 26
Des Moines 25
Milan 25
Tokyo 23
Rome 22
Boston 21
Buffalo 21
Kochi 21
Napoli 18
Redondo Beach 18
Dallas 17
Haiphong 17
Frankfurt am Main 16
Seoul 16
Montreal 15
Falkenstein 14
Heraklion 14
Warsaw 14
Wilmington 14
Da Nang 13
Orem 13
London 12
Brooklyn 11
Chicago 11
Atlanta 10
Fairfield 10
Phoenix 10
Turku 10
Valencia 10
Baghdad 9
Biên Hòa 9
San Francisco 9
Toronto 9
Denver 8
Johannesburg 8
Seattle 8
Boardman 7
Houston 7
Mexico City 7
Redwood City 7
Salerno 7
Salt Lake City 7
Tashkent 7
Can Tho 6
Casalnuovo di Napoli 6
Chennai 6
Grosseto 6
Hải Dương 6
Nanjing 6
Nuremberg 6
Portsmouth 6
Rio de Janeiro 6
Roubaix 6
Stockholm 6
Woodbridge 6
Dublin 5
Guayaquil 5
Memphis 5
Messina 5
Miami 5
Monterrey 5
Ottawa 5
Piscataway 5
Poplar 5
Quito 5
Vienna 5
Ankara 4
Bari 4
Buenos Aires 4
Charlotte 4
Dhaka 4
Düsseldorf 4
Lappeenranta 4
Lucca 4
Madrid 4
Pomigliano d'Arco 4
Princeton 4
Turin 4
Totale 3.200
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 226
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 190
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 176
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 168
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 161
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 161
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 159
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 158
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 150
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 146
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 145
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 143
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 141
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 138
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 138
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 134
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 134
Next generation sequencing in cytology 133
Tumor mutational burden on cytological samples: A pilot study 132
Predictive molecular pathology in the time of COVID-19 131
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 131
Methods for actionable gene fusion detection in lung cancer: now and in the future 131
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 129
Brca1/2 ngs somatic testing in clinical practice: a short report 128
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 127
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 125
Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer? 124
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 123
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 123
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 122
BRAF: A Two-Faced Janus 122
Innovation in next-generation sequencing in non-Small cell lung cancer diagnostics 121
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 121
Liquid biopsy is a promising tool for genetic testing in idiopathic pulmonary fibrosis 121
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 118
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 118
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 116
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 115
Invited review—next-generation sequencing: a modern tool in cytopathology 114
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 114
Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? 108
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study 108
Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience 97
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 95
Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution 62
Analytical reliability of cell-free DNA from fine-needle aspiration rinses for BRAF and NRAS testing in metastatic melanoma 33
Artificial Intelligence in Thyroid Cytopathology: Diagnostic and Technical Insights 28
Next-generation sequencing using a targeted gene panel in advanced solid tumors: five years of experience from an Italian referral institution 13
PIK3CA testing in HR+/HER2− metastatic breast cancer: assessing pathology laboratories capacity and needs 11
Totale 6.062
Categoria #
all - tutte 19.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022247 0 5 9 8 3 9 2 16 16 38 70 71
2022/2023314 31 13 14 11 49 47 3 30 60 33 19 4
2023/2024235 19 49 19 13 9 13 7 27 11 15 25 28
2024/20251.531 57 62 4 9 41 76 133 110 67 236 589 147
2025/20263.252 289 267 347 278 514 152 350 163 393 236 123 140
2026/2027247 82 165 0 0 0 0 0 0 0 0 0 0
Totale 6.062